Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (871 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Glycerin; Glycerine; 1,2,3-Propanetriol; 1,2,3-Trihydroxypropane.
Where it fits in the MeSH classification
- Broader topics
- Triose Sugar Alcohols
Research landscape
PubMed indexes 28,437 records tagged with the MeSH heading “Glycerol” (counts retrieved 2026-10-31). 3,410 of them (12.0%) were published from 2020 onward, and the busiest period so far is through 1999 with 14,374 records.
Reviews account for 832 records (2.9%) and meta-analyses for 24. Randomized controlled trials number 631 (2.2%) as a share of all records on the topic.
Show the data
| Period | Records |
|---|---|
| through 1999 | 14,374 |
| 2000-2009 | 4,631 |
| 2010-2019 | 6,022 |
| 2020 onward | 3,410 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 832 | 2.9% |
| Meta-analyses | 24 | 0.1% |
| Randomized controlled trials | 631 | 2.2% |
Method: PubMed query "Glycerol"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.
Reading the evidence in drugs and chemicals
Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Human adipose glycerol flux is regulated by a pH gate in AQP10 | 2018 | Research article Design not recorded in structured metadata | 106 | cc by PMID 30420639 · DOI · PMC6232157 |
| Yeast's balancing act between ethanol and glycerol production in low-alcohol wines | 2017 | Review article Design not recorded in structured metadata | 83 | cc by PMID 28083938 · DOI · PMC5328816 |
| Tracing the lactate shuttle to the mitochondrial reticulum | 2022 | Review article Design not recorded in structured metadata | 81 | cc by PMID 36075947 · DOI · PMC9534995 |
| Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases | 2026 | Review article Design not recorded in structured metadata | 16 | cc by PMID 40927981 · DOI · PMC12795705 |
Human adipose glycerol flux is regulated by a pH gate in AQP10 [1]
Abstract reading summary — source excerpts
- Opening excerpt
- Obesity is a major threat to global health and metabolically associated with glycerol homeostasis.
- Closing excerpt
- Thus, targeting the cytoplasmic gate to induce constitutive glycerol secretion may offer an attractive option for treating obesity and related complications.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (132 words)
Obesity is a major threat to global health and metabolically associated with glycerol homeostasis. Here we demonstrate that in human adipocytes, the decreased pH observed during lipolysis (fat burning) correlates with increased glycerol release and stimulation of aquaglyceroporin AQP10. The crystal structure of human AQP10 determined at 2.3 Å resolution unveils the molecular basis for pH modulation-an exceptionally wide selectivity (ar/R) filter and a unique cytoplasmic gate. Structural and functional (in vitro and in vivo) analyses disclose a glycerol-specific pH-dependence and pinpoint pore-lining His80 as the pH-sensor. Molecular dynamics simulations indicate how gate opening is achieved. These findings unravel a unique type of aquaporin regulation important for controlling body fat mass. Thus, targeting the cytoplasmic gate to induce constitutive glycerol secretion may offer an attractive option for treating obesity and related complications.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 30420639 · DOI · PMC6232157
Yeast's balancing act between ethanol and glycerol production in low-alcohol wines [2]
Abstract reading summary — source excerpts
- Opening excerpt
- Alcohol is fundamental to the character of wine, yet too much can put a wine off-balance.
- Closing excerpt
- It also casts new light on yeast strain development programmes which, bolstered by synthetic genomics, could potentially overcome these challenges.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (304 words)
Alcohol is fundamental to the character of wine, yet too much can put a wine off-balance. A wine is regarded to be well balanced if its alcoholic strength, acidity, sweetness, fruitiness and tannin structure complement each other so that no single component dominates on the palate. Balancing a wine's positive fruit flavours with the optimal absolute and relative concentration of alcohol can be surprisingly difficult. Over the past three decades, consumers have increasingly demanded wine with richer and riper fruit flavour profiles. In response, grape and wine producers have extended harvest times to increase grape maturity and enhance the degree of fruit flavours and colour intensity. However, a higher degree of grape maturity results in increased grape sugar concentration, which in turn results in wines with elevated alcohol concentration. On average, the alcohol strength of red wines from many warm wine-producing regions globally rose by about 2% (v/v) during this period. Notwithstanding that many of these 'full-bodied, fruit-forward' wines are well balanced and sought after, there is also a significant consumer market segment that seeks lighter styles with less ethanol-derived 'hotness' on the palate. Consumer-focussed wine producers are developing and implementing several strategies in the vineyard and winery to reduce the alcohol concentration in wines produced from well-ripened grapes. In this context, Saccharomyces cerevisiae wine yeasts have proven to be a pivotal strategy to reduce ethanol formation during the fermentation of grape musts with high sugar content (> 240 g l-1 ). One of the approaches has been to develop 'low-alcohol' yeast strains which work by redirecting their carbon metabolism away from ethanol production to other metabolites, such as glycerol. This article reviews the current challenges of producing glycerol at the expense of ethanol. It also casts new light on yeast strain development programmes which, bolstered by synthetic genomics, could potentially overcome these challenges.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28083938 · DOI · PMC5328816
Tracing the lactate shuttle to the mitochondrial reticulum [3]
Abstract reading summary — source excerpts
- Opening excerpt
- Isotope tracer infusion studies employing lactate, glucose, glycerol, and fatty acid isotope tracers were central to the deduction and demonstration of the Lactate Shuttle at the whole-body level.
- Closing excerpt
- Lactate shuttling between driver and recipient cells depends on concentration gradients created by the mitochondrial respiratory apparatus in recipient cells for oxidative disposal of lactate.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (215 words)
Isotope tracer infusion studies employing lactate, glucose, glycerol, and fatty acid isotope tracers were central to the deduction and demonstration of the Lactate Shuttle at the whole-body level. In concert with the ability to perform tissue metabolite concentration measurements, as well as determinations of unidirectional and net metabolite exchanges by means of arterial-venous difference (a-v) and blood flow measurements across tissue beds including skeletal muscle, the heart and the brain, lactate shuttling within organs and tissues was made evident. From an extensive body of work on men and women, resting or exercising, before or after endurance training, at sea level or high altitude, we now know that Organ-Organ, Cell-Cell, and Intracellular Lactate Shuttles operate continuously. By means of lactate shuttling, fuel-energy substrates can be exchanged between producer (driver) cells, such as those in skeletal muscle, and consumer (recipient) cells, such as those in the brain, heart, muscle, liver and kidneys. Within tissues, lactate can be exchanged between white and red fibers within a muscle bed and between astrocytes and neurons in the brain. Within cells, lactate can be exchanged between the cytosol and mitochondria and between the cytosol and peroxisomes. Lactate shuttling between driver and recipient cells depends on concentration gradients created by the mitochondrial respiratory apparatus in recipient cells for oxidative disposal of lactate.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 36075947 · DOI · PMC9534995
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases [4]
Abstract reading summary — source excerpts
- Opening excerpt
- Glycerol and glycerol-3-phosphate (Gro3P) are key metabolites at the intersection of carbohydrate, lipid, and energy metabolism.
- Closing excerpt
- Relevant to chronic metabolic diseases, cancer and aging, glycerol and Gro3P present important translational implications and thus warrant much more attention.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (220 words)
Glycerol and glycerol-3-phosphate (Gro3P) are key metabolites at the intersection of carbohydrate, lipid, and energy metabolism. Their production and usage are organismal and cell-type specific. Glycerol has unique physicochemical properties enabling it to function as an osmolyte, protein structure stabilizer, and an antimicrobial and antifreeze agent, important to the preservation of many biological functions. Glycerol and Gro3P are implicated in many physiological and disease processes relating to energy metabolism, thermoregulation, hydration, skin health, male fertility, aging, and cancer. Glycerol has countless applications in the food, pharmaceutical, and cosmetics industries. It is used as a sweetener, preservative, thickening agent, humectant, osmolyte, and cryoprotectant. It is widely used in skin and wound care products, laxatives, in cell and tissue preservation, and in medicines for numerous conditions. Here, we review the multiple uses and functions of glycerol and Gro3P and associated transporters, enzymes, and target genes in health, senescence, and disease. We discuss the evidence that glycerol may be present at much higher levels in tissues and cells than in the blood. We bring particular focus to the newly identified glycerol shunt in the direct formation of glycerol independent of lipolysis and as a pathway allowing cells to adapt to various stresses. Relevant to chronic metabolic diseases, cancer and aging, glycerol and Gro3P present important translational implications and thus warrant much more attention.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40927981 · DOI · PMC12795705
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation [5]
- Research article Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis [6]
- Research article Glycerol: a promising and abundant carbon source for industrial microbiology [7]
- Research article Glyceroneogenesis and the triglyceride/fatty acid cycle [8]
- Research article Glycerol dissimilation and its regulation in bacteria [9]
- Research article Dendritic polyglycerols for biomedical applications [10]
References
- Gotfryd K, Mósca AF, Missel JW, Truelsen SF, Wang K, Spulber M, et al.. Human adipose glycerol flux is regulated by a pH gate in AQP10. . 2018. PMID 30420639 · DOI · PMC6232157
- Goold HD, Kroukamp H, Williams TC, Paulsen IT, Varela C, Pretorius IS. Yeast's balancing act between ethanol and glycerol production in low-alcohol wines. . 2017. PMID 28083938 · DOI · PMC5328816
- Brooks GA, Curl CC, Leija RG, Osmond AD, Duong JJ, Arevalo JA. Tracing the lactate shuttle to the mitochondrial reticulum. . 2022. PMID 36075947 · DOI · PMC9534995
- Madiraju SRM, Possik E, Al-Mulla F, Nolan CJ, Prentki M. Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases. . 2026. PMID 40927981 · DOI · PMC12795705
- Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer. 2001. PMID 11527683 · DOI
- Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res. 2008. PMID 18757836 · DOI · PMC3837458
- da Silva GP, Mack M, Contiero J. Glycerol: a promising and abundant carbon source for industrial microbiology. Biotechnol Adv. 2009. PMID 18775486 · DOI
- Reshef L, Olswang Y, Cassuto H, Blum B, Croniger CM, Kalhan SC, et al.. Glyceroneogenesis and the triglyceride/fatty acid cycle. J Biol Chem. 2003. PMID 12788931 · DOI
- Lin EC. Glycerol dissimilation and its regulation in bacteria. Annu Rev Microbiol. 1976. PMID 825019 · DOI
- Calderón M, Calderón M, Quadir MA, Sharma SK, Haag R. Dendritic polyglycerols for biomedical applications. Adv Mater. 2010. PMID 20217684 · DOI
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-31.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.